Skip to main content
VulnerabilityPublished

CVE-2026-68067: Quanovate Tech Inc. (operating as Mira / Mira Care) Mira Firmware · Weak Authentication

Affects Quanovate Tech Inc. (operating as Mira / Mira Care) Mira FirmwareSource CVE Database V5

0
Compare

Not known to be exploited · CVSS 9.3 Critical.

Data as of 9 Nov 2026, 23:24 UTC

CVSS 4.0 base score
9.3Critical
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.5% chance of exploitation in 30 days – higher than 43% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 11 Aug 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 10 Nov 2026.

What to do

Affected software

ProductAffectedFixed in
Quanovate Tech Inc. (operating as Mira / Mira Care)Mira FirmwareAffected
  • =1.7.1.47
Fixed in–
Quanovate Tech Inc. (operating as Mira / Mira Care)Mira Android AppAffected
  • =4.5.15.4
Fixed in–

AI-suggested

Until an official fix is released, restrict access to affected systems and monitor for suspicious activity related to account access.

Description

The login endpoint on the Mira cloud API accepts any format-valid string in the password field and returns a live active session token for the account matching the supplied email address. An attacker could use an email address to control cloud accounts and access hormone record information and account settings.

References

Community reviews

Loading reviews…